まとめ
新しい心筋力学薬であるスルマゾールとピモベンデンは,ミオフィラメントのカルシウムに対する感受性を高めることで,心筋収縮を促進します. このカルシウム感受性の効果は,心臓筋における陽性なイノトロピー作用に寄与する.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- 筋肉生理学 筋肉生理学
背景:
- 心筋の収縮は細胞内カルシウムによって調節されますが,この関係は固定されていません.
- 新しい陽性イノトロピク薬は,この関係を調節し,心臓の収縮性に影響を及ぼします.
- 皮を剥いた心臓繊維のカルシウム感受性を研究することで,イオン状態を正確に制御することができます.
研究 の 目的:
- 新規の心臓発作薬,スルマゾールおよびピモベンダンの作用機構を調査する.
- これらの薬がカルシウムに対する心筋筋膜の感受性を調節するかどうかを判断する.
- 薬物の作用におけるトロポニンの役割を調査する.
主な方法:
- 実験は,機能的なサルコプラズマ網膜がない化学的に皮を剥いた哺乳類の心臓繊維で行われました.
- 繊維は,制御されたイオン環境で,異なるカルシウム濃度 (Ca++) に暴露されました.
- カルシウム誘発収縮に対するスルマゾールとピモベンダンの効果を測定した.
主要な成果:
- スルマゾールとピモベンダンは,低カルシウムレベル (1マイクロM) で皮を剥いた心臓繊維のカルシウム誘発収縮を30-50%増加させた.
- この効果は,カルシウムに対するミオフィラメントの感受性の増加に起因し,おそらくスルマゾールに対するトロポニンカルシウム afinityの強化によって引き起こされた.
- トロポニンが欠けていた皮剥がされた滑らかな筋肉の繊維では,効果は見られなかった.
結論:
- スルマゾールとピモベンダンの陽性なイノトロピー効果は,部分的には,心臓のミオフィラメントに対するカルシウム感受性の作用によるものかもしれない.
- これらの薬は,カルシウムに対する心筋の収縮反応を強化します.
- 細胞内自由カルシウムを増加させる他のメカニズムも,その全体的な効果に寄与する可能性があります.
さらに関連する動画
08:29Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
関連する概念動画
Relaxation of Skeletal Muscles
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Smooth Muscle Contraction
Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
